Effectiveness of blood flow restriction training after bone-patellar tendon-bone anterior cruciate ligament reconstruction: a randomized placebo-controlled trial

Phase 3

Completed

Conditions: Anterior cruciate ligament (ACL) reconstruction
10043237

Registration Number: NL-OMON49262

Lead Sponsor: Zuyderland Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 35

Inclusion Criteria

Patients who underwent primary bone-patellar tendon-bone anterior cruciate
ligament reconstruction

Exclusion Criteria

Patients known with
• diabetes
• sickle cell anemia
• severe hypertension
• renal compromise
• venous thromboembolism
• extremity infection
• lymphadenectomy
• cancer

Study & Design

Study Type: Observational non invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcomes are: quadriceps and hamstring strength 8-, 14-, 26-, 39- and<br /><br>52-weeks after BPTB ACL reconstruction. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes are leg muscle size, physical function, patient<br /><br>satisfaction, patient confidence, knee laxity, knee pain and knee effusion 8-,<br /><br>14-, 26-, 39- and 52-weeks after BPTB ACL reconstruction. Furthermore,<br /><br>completion of revalidation and adverse events will be documented.</p><br>